Skip to main content
ANI Pharmaceuticals, Inc.SEC 8-K

ANI Pharmaceuticals announces public offer to acquire Egetis Therapeutics

What happened

ANI Pharmaceuticals has made a public offer for the shares, convertible loan, and warrants of Sweden-based Egetis Therapeutics.

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Nov 16, 2026

More SEC 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1023024
Accession number
0001023024-26-000082
Filing year
2026
Fiscal year end
11/16
Why it matters
Integration needs coming
Signal category
Strategic

Topics and mentions

Regions named

  • Sweden
  • United States

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 17, 2026
signal_type
sec-8k
signal_subtype
acquisitionAnnounced

Use this data

Get every SEC 8-K signal for ANI Pharmaceuticals, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ANI Pharmaceuticals, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/152289fe-c1ee-41e0-a72e-9797bf7d799a returns this record as JSON. POST /v1/companies/enrich returns every signal for anipharmaceuticals.com.

{
  "signal_id": "152289fe-c1ee-41e0-a72e-9797bf7d799a",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-11-17T07:03:13.706+00:00",
  "company": {
    "name": "ANI Pharmaceuticals, Inc.",
    "domain": "anipharmaceuticals.com"
  },
  "data": {
    "detail": "ANI Pharmaceuticals has made a public offer for the shares, convertible loan, and warrants of Sweden-based Egetis Therapeutics. For sellers: Cross-border life sciences M&A often creates opportunities for integration consulting, regulatory compliance, and post-merger systems harmonization.",
    "summary": "ANI Pharmaceuticals announces public offer to acquire Egetis Therapeutics",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1023024/000102302426000082/ani-20261116.htm",
    "filing_date": "2026-11-16",
    "filing_year": 2026,
    "fiscal_year_end": "11/16",
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic",
    "regions_mentioned": [
      "Sweden",
      "United States"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.